24
Jun 2026
Eating 90 g of wholegrains daily linked to lower breast cancer risk
Research indicates that long-term wholegrain intake per Nordic guidelines is associated with reduced breast cancer risk, emphasizing food type differences.
Stay Informed!
24
Jun 2026
Plant-based Mediterranean-style diet cuts heart disease risk by 26%
A 20-year study links plant-based Mediterranean diets to lower heart disease risk, highlighting the importance of sustainable eating for cardiovascular health.
24
Jun 2026
Faster biological aging may explain rising early-onset cancers
The link between biological aging and early-onset cancer risk offers crucial insights into generational health trends and potential preventive measures.
24
Jun 2026
FairJourney Bio and AbTherx partner to offer fully integrated antibody discovery
FairJourney Bio (“FJBio”), a global antibody discovery expert, has entered a partnership with AbTherx, Inc. to bring transgenic mouse-based antibody discovery in-house. The agreement gives the Company access to AbTherx’s Atlas™ Full Human Diversity (FHD) and Common Light Chain (cLC) mouse technologies, completing a discovery route that partners can now run end to end entirely within FJBio’s integrated workflow.
24
Jun 2026
Human-AI teams improve healthcare only when clinicians stay in control
A scoping review of 140 empirical studies found that human-AI collaboration in healthcare reports the most consistent benefits in diagnostic interpretation, especially when AI supports bounded tasks and clinicians retain final responsibility. Evidence remains fragmented across triage, treatment planning, and documentation, with few studies measuring patient outcomes, system impact, trust calibration, or governance in real-world settings.
24
Jun 2026
Lost weight is less likely to return when exercise follows obesity treatment
A systematic review and meta-analysis of 11 randomized controlled trials found that exercise during the post-weight-loss maintenance phase reduced weight regain by an average of 2.81 kg compared with control groups. Evidence for fat-mass reduction remained inconclusive, highlighting the need for longer, standardized trials with better adherence and body-composition monitoring.
24
Jun 2026
Early diabetes drug treatment links to better survival after diagnosis thresholds
A Korean target trial emulation found that starting antidiabetic medication within 12 months of newly crossing type 2 diabetes diagnostic thresholds was associated with lower five-year all-cause mortality. MACE risk was numerically lower with earlier treatment, but the reductions in cardiovascular events were not statistically significant, underscoring the need for larger studies.
23
Jun 2026
Strength training plus cardio cuts type 2 diabetes risk the most
A 20-year prospective cohort study of 143,715 US healthcare professionals found that long-term resistance training was associated with a substantially lower risk of type 2 diabetes. The lowest risk was seen among participants who combined regular resistance training with adequate aerobic activity and limited TV viewing.
23
Jun 2026
Melatonin improves skin flap survival by reducing ferroptosis
Random-pattern skin flaps are widely used to repair defects caused by trauma, burns, tumor removal, and other injuries because they can be designed without depending on a single named blood vessel.
23
Jun 2026
New microneedle patch offers enzyme-free continuous glucose monitoring
More than 500 million people worldwide live with diabetes, making reliable continuous glucose monitoring (CGM) a critical yet unmet need.
